Cocrystal Pharma, Inc.·4

May 7, 6:21 PM ET

Schinazi Raymond F 4

4 · Cocrystal Pharma, Inc. · Filed May 7, 2018

Insider Transaction Report

Form 4
Period: 2018-05-03
Schinazi Raymond F
Director10% Owner
Transactions
  • Award

    Common Stock

    2018-05-03$1.90/sh+420,737$799,400722,226 total(indirect: By LP)
Holdings
  • Common Stock

    (indirect: By LLC)
    929,525
  • Common Stock

    9,240,928

Documents

1 file
  • 4
    form4.xmlPrimary